4//SEC Filing
McCullough David 4
Accession 0001127602-10-007599
CIK 0000882796other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 6:24 PM ET
Size
5.4 KB
Accession
0001127602-10-007599
Insider Transaction Report
Form 4
Transactions
- Award
Emp. Stock Option (Right to Buy)
2010-03-01+55,000→ 55,000 totalExercise: $6.68Exp: 2020-03-01→ Common Stock (55,000 underlying)
Footnotes (1)
- [F1]Options become exercisable at the rate of 25% after 1 year and then 1/48 per month thereafter until fully vested and exercisable after 48 months.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001395238
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 6:24 PM ET
- Size
- 5.4 KB